1-3 of 3
Christos Hatzis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial

Vasiliki Pelekanou, William E. Barlow, Zeina A. Nahleh, Brad Wasserman, Ying-Chun Lo, Marie-Kristin von Wahlde, Daniel Hayes, Gabriel N. Hortobagyi, Julie Gralow, Debu Tripathy, Peggy Porter, Borbala Szekely, Christos Hatzis, David L. Rimm, Lajos Pusztai
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (6): 1324–1331.
https://doi.org/10.1158/1535-7163.MCT-17-1005
Published: 31 May 2018
View article titled, Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial
Open the PDF for Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial in another window
Journal Articles

Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor

Casey G. Langdon, James T. Platt, Robert E. Means, Pinar Iyidogan, Ramanaiah Mamillapalli, Michael Klein, Matthew A. Held, Jong Woo Lee, Ja Seok Koo, Christos Hatzis, Howard S. Hochster, David F. Stern
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (6): 1041–1053.
https://doi.org/10.1158/1535-7163.MCT-16-0794
Published: 01 June 2017
View article titled, Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
Open the PDF for Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor in another window
Includes: Supplementary data
Journal Articles

Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy

Stacy Moulder, Kai Yan, Fei Huang, Kenneth R. Hess, Cornelia Liedtke, Feng Lin, Christos Hatzis, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (5): 1120–1127.
https://doi.org/10.1158/1535-7163.MCT-09-1117
Published: 09 May 2010
View article titled, Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy
Open the PDF for Development of Candidate Genomic Markers to Select Breast Cancer Patients for Dasatinib Therapy in another window
Includes: Supplementary data